Page last updated: 2024-10-15

pycnidione

Description

pycnidione: potentiator of bleomycin; isolated from Gloeotinia; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135454124
CHEMBL ID429319
SCHEMBL ID2552893
MeSH IDM0574373

Synonyms (4)

Synonym
pycnidione
CHEMBL429319
bdbm50373178
SCHEMBL2552893
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Stromelysin-1Homo sapiens (human)IC50 (µMol)31.00000.00001.148410.0000AID319057
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (17)

Processvia Protein(s)Taxonomy
proteolysisStromelysin-1Homo sapiens (human)
extracellular matrix disassemblyStromelysin-1Homo sapiens (human)
protein catabolic processStromelysin-1Homo sapiens (human)
regulation of cell migrationStromelysin-1Homo sapiens (human)
collagen catabolic processStromelysin-1Homo sapiens (human)
positive regulation of protein-containing complex assemblyStromelysin-1Homo sapiens (human)
cellular response to reactive oxygen speciesStromelysin-1Homo sapiens (human)
innate immune responseStromelysin-1Homo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionStromelysin-1Homo sapiens (human)
cellular response to lipopolysaccharideStromelysin-1Homo sapiens (human)
cellular response to amino acid stimulusStromelysin-1Homo sapiens (human)
cellular response to UV-AStromelysin-1Homo sapiens (human)
cellular response to nitric oxideStromelysin-1Homo sapiens (human)
regulation of neuroinflammatory responseStromelysin-1Homo sapiens (human)
response to amyloid-betaStromelysin-1Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processStromelysin-1Homo sapiens (human)
extracellular matrix organizationStromelysin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (7)

Processvia Protein(s)Taxonomy
endopeptidase activityStromelysin-1Homo sapiens (human)
metalloendopeptidase activityStromelysin-1Homo sapiens (human)
serine-type endopeptidase activityStromelysin-1Homo sapiens (human)
protein bindingStromelysin-1Homo sapiens (human)
peptidase activityStromelysin-1Homo sapiens (human)
metallopeptidase activityStromelysin-1Homo sapiens (human)
zinc ion bindingStromelysin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
extracellular regionStromelysin-1Homo sapiens (human)
nucleusStromelysin-1Homo sapiens (human)
mitochondrionStromelysin-1Homo sapiens (human)
cytosolStromelysin-1Homo sapiens (human)
extracellular matrixStromelysin-1Homo sapiens (human)
extracellular spaceStromelysin-1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID492430Antimalarial activity against Plasmodium falciparum W22009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Antimalarials from nature.
AID319057Inhibition of stromelysin mediated beta-casein cleavage2008Journal of natural products, Mar, Volume: 71, Issue:3
Noreupenifeldin, a tropolone from an unidentified ascomycete.
AID401116Induction of human erythropoietin gene expression in human Hep3B cells over expressing human EPO assessed as maximum induction ratio at 4.3 uM by luciferase reporter gene assay relative to control1998Journal of natural products, Jun-26, Volume: 61, Issue:6
Epolones: novel sesquiterpene-tropolones from fungus OS-F69284 that induce erythropoietin in human cells.
AID401118Cytotoxicity against human Hep3B cells after 48 hrs by MTT assay1998Journal of natural products, Jun-26, Volume: 61, Issue:6
Epolones: novel sesquiterpene-tropolones from fungus OS-F69284 that induce erythropoietin in human cells.
AID401115Induction of human erythropoietin gene expression in human Hep3B cells over expressing human EPO assessed as concentration required to produce 5-fold induction ratio by luciferase reporter gene assay relative to control1998Journal of natural products, Jun-26, Volume: 61, Issue:6
Epolones: novel sesquiterpene-tropolones from fungus OS-F69284 that induce erythropoietin in human cells.
AID319056Anthelmintic activity against Haemonchus contortus assessed as reduction in L3 larval motility2008Journal of natural products, Mar, Volume: 71, Issue:3
Noreupenifeldin, a tropolone from an unidentified ascomycete.
AID401117Induction of erythropoietin secretion in human Hep3B cells expressing human EPO at 10 uM by ELISA1998Journal of natural products, Jun-26, Volume: 61, Issue:6
Epolones: novel sesquiterpene-tropolones from fungus OS-F69284 that induce erythropoietin in human cells.
AID492443Antimalarial activity against Plasmodium falciparum D62009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Antimalarials from nature.
AID492450Antimalarial activity against Plasmodium falciparum FCR3F862009Bioorganic & medicinal chemistry, May-01, Volume: 17, Issue:9
Antimalarials from nature.
AID319058Induction of erythropoietin gene expression at 1 to 1.6 uM relative to control2008Journal of natural products, Mar, Volume: 71, Issue:3
Noreupenifeldin, a tropolone from an unidentified ascomycete.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]